CLAIM #22736 · EMR (EMR) · 2024Q3 earnings call · Aug 7, 2024 · due Dec 31, 2025
“We foresee sales turning positive there in the second half of 2025 with orders turning positive in the first half of 2025.”
Lal Karsanbhai · CEO
CANNOT_DETERMINE
resolved by a revision, graded at the moved level · official band 5 percent
Committed
We foresee sales turning positive there in the second half of 2025 with orders turning positive in the first half of 2025.
Reported
We have lowered our full year outlook for our discrete businesses to the low single digit range.
Verify independently
SEC filings for EMR ↗ · Claim quote is verbatim from the 2024Q3 earnings call.